Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Callahan

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
European Urology Open Science|October 3, 2022
Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell CarcinomaCristian Udovicich, Jason Callahan, Mathias Bressel, et al.
Journal for Immunotherapy of Cancer|October 16, 2020
Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinomaAlison M Weppler, Andrew Pattison, Prachi Bhave, et al.
BMJ Open|December 11, 2020
Single-arm prospective interventional study assessing feasibility of using gallium-68 ventilation and perfusion PET/CT to avoid functional lung in patients with stage III non-small cell lung cancerNicholas Bucknell, Nicholas Hardcastle, Price Jackson, et al.
BMJ Open|November 18, 2022
ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with <sup>89</sup>Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocolFiona Hegi-Johnson, Stacey E Rudd, Christian Wichmann, et al.
International Journal of Radiation Oncology, Biology, Physics|July 5, 2023
PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 StudyFiona Hegi-Johnson, Stacey E Rudd, Christian W Wichmann, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 15, 2018
Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer's DiseaseBarbara R Cardoso, Blaine R Roberts, Charles B Malpas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2018
<sup>64</sup>Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide TherapyRodney J Hicks, Price Jackson, Grace Kong, et al.
Cancer Discovery|June 30, 2022
Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II StudyPeter Savas, Louisa L Lo, Stephen J Luen, et al.
Blood|April 19, 2015
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencingDavid M Kurtz, Michael R Green, Scott V Bratman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2025
Fully Automated Image-Based Multiplexing of Serial PET/CT Imaging for Facilitating Comprehensive Disease PhenotypingLalith Kumar Shiyam Sundar, Sebastian Gutschmayer, Manuel Pires, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
European Urology Open Science|October 3, 2022
Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell CarcinomaCristian Udovicich, Jason Callahan, Mathias Bressel, et al.
Journal for Immunotherapy of Cancer|October 16, 2020
Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinomaAlison M Weppler, Andrew Pattison, Prachi Bhave, et al.
BMJ Open|December 11, 2020
Single-arm prospective interventional study assessing feasibility of using gallium-68 ventilation and perfusion PET/CT to avoid functional lung in patients with stage III non-small cell lung cancerNicholas Bucknell, Nicholas Hardcastle, Price Jackson, et al.
BMJ Open|November 18, 2022
ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with <sup>89</sup>Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocolFiona Hegi-Johnson, Stacey E Rudd, Christian Wichmann, et al.
International Journal of Radiation Oncology, Biology, Physics|July 5, 2023
PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 StudyFiona Hegi-Johnson, Stacey E Rudd, Christian W Wichmann, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 15, 2018
Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer's DiseaseBarbara R Cardoso, Blaine R Roberts, Charles B Malpas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2018
<sup>64</sup>Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide TherapyRodney J Hicks, Price Jackson, Grace Kong, et al.
Cancer Discovery|June 30, 2022
Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II StudyPeter Savas, Louisa L Lo, Stephen J Luen, et al.
Blood|April 19, 2015
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencingDavid M Kurtz, Michael R Green, Scott V Bratman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2025
Fully Automated Image-Based Multiplexing of Serial PET/CT Imaging for Facilitating Comprehensive Disease PhenotypingLalith Kumar Shiyam Sundar, Sebastian Gutschmayer, Manuel Pires, et al.
Pageof 9